Abstract
Abacavir pronucleotide nanoformulations (NM3ABC) were prepared as a novel long acting slow effective release antiretroviral therapy. Single NM3ABC treatment of human monocyte-derived macrophages produced sustained intracellular carbovir-triphosphate and antiretroviral activities for up to 30 days.
Cite
CITATION STYLE
APA
Lin, Z., Gautam, N., Alnouti, Y., McMillan, J., Bade, A. N., Gendelman, H. E., & Edagwa, B. (2018). ProTide generated long-acting abacavir nanoformulations. Chemical Communications, 54(60), 8371–8374. https://doi.org/10.1039/c8cc04708a
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free